# Tarceva. ICORG 08-41

> **NCT01721252** · — · COMPLETED · sponsor: **Cancer Trials Ireland** · enrollment: 200 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01721252
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2015-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721252, "Tarceva. ICORG 08-41". Retrieved via MORVS 2026-10-31 from https://api.morvs.ai/clinical/NCT01721252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*